检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王贤正[1] 钱梦[1] 谢鸣[1] Wang Xianzheng Qian Meng Xie Ming(Department of Formulaology, Beijing University of Chinese Medicine, Beijing 100029, China)
出 处:《中国药师》2017年第9期1578-1583,共6页China Pharmacist
摘 要:多巴制剂是目前临床上治疗帕金森病的首选药物。随着多巴制剂应用时间的延长和用量的加大,其治疗作用越来越小,不良反应反而越来越大,已成为影响其临床应用的主要问题。研究表明,中医药与多巴制剂联合应用具有提高疗效、减少西药的用量及减轻其不良反应等作用。本文就近十年来多巴制剂联合中医药治疗帕金森病的进展进行评述。Dopa preparations are currently first choice for the clinical treatment of Parkinson ' s disease. With the application time extension and the dose increase of dopa preparations, the therapeutic effect is smaller and smaller, while the side effects are more and more significant, which have become the main problems affecting their clinical application. The current researches showed that the combination of traditional Chinese medicines and dopa preparations can improve the efficacy, decrease the dose of western medicines, reduce the adverse effects and so on. The paper reviewed the progress in the combination of dopa preparations and traditional Chinese medicines in the treatment of Parkinson' s disease in recent ten years.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249